Tripling tobacco tax globally would cut smoking by a third, and prevent 200 million premature deaths this century from lung cancer and other diseases, according to a Cancer Research UK review published in the New England Journal of Medicine.
Boosting the tax by a large fixed amount per cigarette would narrow the price gap between the most and least expensive cigarettes, so it would encourage people to quit smoking altogether rather than switch to a cheaper brand, and would help stop young people from starting.
This would be especially effective in low-to-middle-income countries where the cheapest cigarettes are relatively affordable. But it would also be effective in richer countries: France halved cigarette consumption from 1990 to 2005 by raising taxes well above inflation.
Study co-author Professor Sir Richard Peto, Cancer Research UK epidemiologist, said: “The two certainties in life are death and taxes. We want higher tobacco taxes and fewer tobacco deaths. It would help children not to start, and it would help many adults to stop while there’s still time.
“Globally, about half of all young men and one in ten of all young women become smokers, and, particularly in developing countries, relatively few quit. If they keep smoking, about half will be killed by it, but if they stop before 40, they’ll reduce their risk of dying from tobacco by 90 per cent.”
He added: “The international tobacco industry makes about £30bn ($50bn) in profits each year – that’s a profit of approximately £6,000 ($10,000) per death from smoking.”
Governments have agreed to prioritise reducing premature deaths from cancer and other chronic diseases in the United Nations General Assembly and in the WHO’s 2013 World Health Assembly. Smoking is the largest cause of premature death from chronic disease, and governments agreed a global target of reducing smoking by a third by 2025.
Tripling tobacco taxes would decrease worldwide consumption by about a third, but despite this it would also increase government revenues from tobacco by a third, from £180bn (US$300bn) a year now to £240bn (US$400bn) a year – income which could be spent on better healthcare.
In the European Union, tobacco now causes 300,000 deaths a year under the age of 70 (250,000 men, 50,000 women). An EU-wide doubling of cigarette prices would prevent 100,000 deaths a year in the under 70s.
Co-author Professor Prabhat Jha, University of Toronto, said: “Controlling tobacco marketing is also key to helping people give up smoking.”
In the UK an independent review concluded that standardised plain packaging would reduce the appeal of cigarettes. The UK could be ready to switch to standardised plain cigarette packaging before the next election. Australia changed to standardised plain packaging in 2012 – a measure New Zealand plans to copy.
Dr Harpal Kumar, Cancer Research UK’s chief executive, said: “Worldwide, around half a billion children and adults under the age of 35 are already – or soon will be – smokers, and many will be hooked on tobacco for life. So there’s an urgent need for Governments to find ways to stop people starting and to help smokers give up. This immensely important study demonstrates that tobacco taxes are a hugely powerful lever, and potentially a triple win – reducing the numbers of people who smoke and who die from their addiction, reducing the health care burden and costs associated with smoking and yet, at the same time, increasing Government income. We urge all Governments, not least the UK Government, to take action by regularly raising tobacco taxes above inflation, and using occasional steep tax hikes starting with the next budget.
“Young adult smokers will lose about a decade of life if they continue to smoke – they’ve so much to gain by stopping.”
Source: CRUK
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.